Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Medications

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison

le Roux CW, Hankosky ER, Wang D, Malik R, Yu M, Hickey A, Kan H, Bunck MC, Stefanski A, Garcia-Perez LE, Wharton S. Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison Diabetes Obes Metab

Balancing the scales: the interplay of diet, exercise, GLP-1 receptor agonists, and obesity in shaping male reproductive health

Ammar OF, Sharma K, Liperis G, Fraire-Zamora JJ, Serdarogullari M, Ali ZE, Ramasamy R, Laurentino S, Watkins A, Mincheva M. Balancing the scales: the interplay of diet, exercise, GLP-1 receptor agonists, and obesity in shaping male reproductive health Hum Reprod

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM; SURMOUNT-2 investigators. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Lancet
Insulin Resistance & Diabetes

Chronic Semaglutide Treatment in Rats Leads to Daily Excessive Concentration-Dependent Sucrose Intake

Cawthon CR, Blonde GD, Nisi AV, Bloomston HM, Krubitski B, le Roux CW, Spector AC. Chronic Semaglutide Treatment in Rats Leads to Daily Excessive Concentration-Dependent Sucrose Intake J Endocr Soc

Pharmacotherapy for chronic obesity management: a look into the future

Abdel-Malek M, Yang L, Miras AD. Pharmacotherapy for chronic obesity management: a look into the future Intern Emerg Med

Balancing the scales: the interplay of diet, exercise, GLP-1 receptor agonists, and obesity in shaping male reproductive health

Ammar OF, Sharma K, Liperis G, Fraire-Zamora JJ, Serdarogullari M, Ali ZE, Ramasamy R, Laurentino S, Watkins A, Mincheva M. Balancing the scales: the interplay of diet, exercise, GLP-1 receptor agonists, and obesity in shaping male reproductive health Hum Reprod

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison

le Roux CW, Hankosky ER, Wang D, Malik R, Yu M, Hickey A, Kan H, Bunck MC, Stefanski A, Garcia-Perez LE, Wharton S. Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison Diabetes Obes Metab

Could capsaicinoids help to support weight management? A systematic review and meta-analysis of energy intake data

S. Whiting; E. J. Derbyshire; B. Tiwari Could capsaicinoids help to support weight management? A systematic review and meta-analysis of energy intake data Appetite
Appetite & Satiety

Weight loss and long-term weight loss maintenance with naltrexone ER/bupropion ER combination therapy

C. Le Roux; M. Burrows; J. Blavignac; F. Camacho; E. Gould; M. Barakat Weight loss and long-term weight loss maintenance with naltrexone ER/bupropion ER combination therapy Obesity reviews

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

D. C. W. Lau; L. Erichsen; A. M. Francisco; A. Satylganova; C. W. le Roux; B. McGowan; S. D. Pedersen; K. H. Pietilainen; D. Rubino; R. L. Batterham Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial Lancet

Older posts

Newer posts

← Previous Page1 … Page4 Page5 Page6 … Page18 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI